Determination of receptor-bound drug conformations by QSAR using flexible fitting to derive a molecular similarity index

SummaryResults are presented for a QSAR analysis of bisamidines, using a similarity index as descriptor. The method allows for differences in conformation of bisamidines at the receptor site to be taken into consideration. In particular, it has been suggested by others that pentamidine binds in the minor groove of DNA in a so-called isohelical conformation, and our QSAR supports this suggestion. The molecular similarity index for comparison of molecules can be used as a parameter for correlating and hence rationalising the activity as well as suggesting the design of bioactive molecules. The studied compounds had been evaluated for potency against Leishmania mexicana amazonensis, and this potency was used as a dependent variable in a series of QSAR analyses. For the calculation of similarity indexes, each analogue was in turn superimposed on a chosen lead compound in a reference conformation, either extended or isohelical, maximising overlap and hence similarity by flexible fitting.

[1]  D. Koshland,et al.  Enzyme flexibility and enzyme action. , 1959, Journal of cellular and comparative physiology.

[2]  S Neidle,et al.  NMR and molecular modeling studies of the interaction of berenil and pentamidine with d(CGCAAATTTGCG)2. , 1993, European journal of biochemistry.

[3]  L B Kier,et al.  Derivation and significance of valence molecular connectivity. , 1981, Journal of pharmaceutical sciences.

[4]  D. E. Koshl,et al.  Regulatory control through conformation changes in proteins , 1968 .

[5]  Corwin Hansch,et al.  SUBSTITUENT CONSTANTS FOR CORRELATION ANALYSIS , 1977 .

[6]  Lemont B. Kier,et al.  Determination of Topological Equivalence in Molecular Graphs from the Topological State , 1990 .

[7]  Lemont B. Kier,et al.  A Shape Index from Molecular Graphs , 1985 .

[8]  W. G. Richards,et al.  Rapid evaluation of shape similarity using Gaussian functions , 1993, J. Chem. Inf. Comput. Sci..

[9]  Andrew C. Good,et al.  Similarity screening of molecular data sets , 1992, J. Comput. Aided Mol. Des..

[10]  S. So,et al.  Application of neural networks: quantitative structure-activity relationships of the derivatives of 2,4-diamino-5-(substituted-benzyl)pyrimidines as DHFR inhibitors. , 1992, Journal of medicinal chemistry.

[11]  J. Hall,et al.  Structure-activity relationships of pentamidine analogs against Giardia lamblia and correlation of antigiardial activity with DNA-binding affinity , 1991, Antimicrobial Agents and Chemotherapy.

[12]  Y. Martin,et al.  Quantitative drug design , 1978 .

[13]  J G Cannon,et al.  Small ring analogs of acetylcholine. Synthesis and absolute configurations of cyclopropane derivatives. , 1970, Journal of medicinal chemistry.

[14]  Malcolm F. G. Stevens,et al.  Crystal structure and molecular modelling of the antimicrobial drug pentamidine , 1989 .

[15]  R R Tidwell,et al.  Pentamidine congeners. 2. 2-butene-bridged aromatic diamidines and diimidazolines as potential anti-Pneumocystis carinii pneumonia agents. , 1994, Journal of medicinal chemistry.

[16]  Ramon Carbo,et al.  How similar is a molecule to another? An electron density measure of similarity between two molecular structures , 1980 .

[17]  S Neidle,et al.  Structural studies on bio-active compounds. Part XIV. Molecular modelling of the interactions between pentamidine and DNA. , 1990, Anti-cancer drug design.

[18]  Andrew C. Good,et al.  Utilization of Gaussian functions for the rapid evaluation of molecular similarity , 1992, J. Chem. Inf. Comput. Sci..

[19]  A. Good,et al.  Structure-activity relationships from molecular similarity matrices. , 1993, Journal of medicinal chemistry.

[20]  Aalt Bast,et al.  Comprehensive medicinal chemistry , 1991 .

[21]  Lemont B. Kier,et al.  The Electrotopological State: An Atom Index for QSAR , 1991 .

[22]  Lemont B. Kier,et al.  An index of electrotopological state for atoms in molecules , 1991 .

[23]  D. Koshland.  Application of a Theory of Enzyme Specificity to Protein Synthesis. , 1958, Proceedings of the National Academy of Sciences of the United States of America.

[24]  A. Good,et al.  The calculation of molecular similarity: alternative formulas, data manipulation and graphical display. , 1992, Journal of molecular graphics.

[25]  L. Kier.  Distinguishing Atom Differences in a Molecular Graph Shape Index , 1986 .

[26]  R Benigni,et al.  Molecular similarity matrices and quantitative structure-activity relationships: a case study with methodological implications. , 1995, Journal of medicinal chemistry.

[27]  L. Kier.  Inclusion of Symmetry as a Shape Attribute in Kappa Index Analysis , 1987 .

[28]  L B Kier,et al.  Molecular connectivity of phenols and their toxicity to fish , 1984, Bulletin of environmental contamination and toxicology.

[29]  W. L. Nelson,et al.  Conformational aspects of acetylcholine receptor sites. The isomeric 3-trimethylammonium-2-acetoxy-trans-decalin halides and the isomeric alpha,beta-dimethylacetylcholine halides. , 1966, Journal of medicinal chemistry.

[30]  J. Hall,et al.  Analogues of 1,5-bis(4-amidinophenoxy)pentane (pentamidine) in the treatment of experimental Pneumocystis carinii pneumonia. , 1990, Journal of medicinal chemistry.

[31]  S Neidle,et al.  Crystal structure of a pentamidine-oligonucleotide complex: implications for DNA-binding properties. , 1992, Biochemistry.

[32]  S Wold,et al.  Multivariate data analysis and experimental design in biomedical research. , 1988, Progress in medicinal chemistry.

[33]  A. Leo,et al.  Substituent constants for correlation analysis in chemistry and biology , 1979 .

[34]  S Neidle,et al.  Interaction of berenil with the EcoRI dodecamer d(CGCGAATTCGCG)2 in solution studied by NMR. , 1991, Biochemistry.

[35]  Barry L. Levinson,et al.  Quantitative Drug Design: A Critical Introduction , 1979, The Yale Journal of Biology and Medicine.

[36]  D. Kyle,et al.  Structure-activity relationships of analogs of pentamidine against Plasmodium falciparum and Leishmania mexicana amazonensis , 1990, Antimicrobial Agents and Chemotherapy.